Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Boosted by Fiduciary Alliance LLC

Fiduciary Alliance LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,497 shares of the medical equipment provider’s stock after acquiring an additional 3,151 shares during the quarter. Fiduciary Alliance LLC’s holdings in Intuitive Surgical were worth $6,523,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Jupiter Asset Management Ltd. bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $364,000. Wealthspire Advisors LLC raised its position in shares of Intuitive Surgical by 10.9% during the second quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock worth $509,000 after acquiring an additional 113 shares during the last quarter. Wrapmanager Inc. lifted its stake in shares of Intuitive Surgical by 8.1% during the second quarter. Wrapmanager Inc. now owns 811 shares of the medical equipment provider’s stock valued at $361,000 after acquiring an additional 61 shares during the period. Prosperity Consulting Group LLC boosted its holdings in Intuitive Surgical by 24.4% in the second quarter. Prosperity Consulting Group LLC now owns 1,831 shares of the medical equipment provider’s stock valued at $815,000 after acquiring an additional 359 shares during the last quarter. Finally, J.W. Cole Advisors Inc. raised its holdings in Intuitive Surgical by 37.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 2,767 shares of the medical equipment provider’s stock worth $1,231,000 after purchasing an additional 750 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.6 %

ISRG traded down $9.02 during trading hours on Monday, hitting $538.45. The stock had a trading volume of 167,400 shares, compared to its average volume of 1,170,794. The stock has a market cap of $191.78 billion, a PE ratio of 86.57, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23. The company’s fifty day simple moving average is $535.93 and its 200 day simple moving average is $495.17.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.